TPWA
PRAX icon

Twin Peaks Wealth Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$1.61K – 1675
2026
Q1 		$1.61K Buy
+5
New +$1.55K ﹤0.01% 1775
2025
Q3 		– Sell
-1
Closed -$48 – 1594
2025
Q2 		$48 Buy
+1
New +$38 ﹤0.01% 2194

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Twin Peaks Wealth Advisors's PRAX Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 5 shares — an estimated $1.61K sold.

Twin Peaks Wealth Advisors first reported a position in PRAX in Q2 2025 and held it in 2 quarters. The position peaked at $1.61K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 5 Praxis Precision Medicines shares in Q2 2026, an estimated $1.61K.
  • Twin Peaks Wealth Advisors first reported a position in Praxis Precision Medicines in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Praxis Precision Medicines position peaked at $1.61K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.